Analysis of the Global Human Albumin Market and Product Pipeline

Emerging Economies and Use of Human Albumin as an Excipient Present New Growth Opportunities
Share this:
     
Published: 2 Sep 2015

The study covers provides an assessment of the marketed and pipeline products for the global human albumin market. Segmentation by application has been provided along with additional information such as clinical trial timelines and results, and historical and projected launch timelines. The marketed and pipeline products have been broadly segmented into those used in replacement therapy (fluid-volume replacement therapy), in drug formulation and delivery, as stabilisers for vaccines, and as excipients in imaging and in-vitro fertilisation products. The market shares of the key companies operating in this space have also been listed.

  1.  
  2.  
  3.  
  4.  
  5.  
  6.  
  7.  
  8.  

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..